121 related articles for article (PubMed ID: 20227944)
1. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid.
Bender DA
Biochem Pharmacol; 1980 Mar; 29(5):707-12. PubMed ID: 20227944
[TBL] [Abstract][Full Text] [Related]
2. Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
Bender DA
Biochem Pharmacol; 1980 Aug; 29(15):2099-104. PubMed ID: 6447505
[No Abstract] [Full Text] [Related]
3. Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
Bender DA; Earl CJ; Lees AJ
Clin Sci (Lond); 1979 Jan; 56(1):89-93. PubMed ID: 477187
[TBL] [Abstract][Full Text] [Related]
4. Effects of benserazide and carbidopa on the metabolism of L-tryptophan by isolated rat liver cells.
Smith SA; Pogson CI
Biochem Pharmacol; 1981 Mar; 30(6):623-8. PubMed ID: 7271899
[No Abstract] [Full Text] [Related]
5. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
[TBL] [Abstract][Full Text] [Related]
6. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
8. Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
Magnussen I; Van Woert MH
Eur J Clin Pharmacol; 1982; 23(1):81-6. PubMed ID: 6182005
[TBL] [Abstract][Full Text] [Related]
9. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
Polleri A; Masturzo P; Murialdo G; Carolei A
Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tryptophan metabolism by oestrogens in the rat: a factor in the aetiology of pellagra.
Bender DA; Totoe L
Br J Nutr; 1984 Mar; 51(2):219-24. PubMed ID: 6231048
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of the oxidation of carbidopa and benserazide by tyrosinase and peroxidase.
Munoz-Munoz JL; Garcia-Molina F; Garcia-Molina M; Tudela J; García-Cánovas F; Rodriguez-Lopez JN
Biosci Biotechnol Biochem; 2009 Jun; 73(6):1308-13. PubMed ID: 19502746
[TBL] [Abstract][Full Text] [Related]
12. The effects of a dietary excess of leucine on the synthesis of nicotinamide nucleotides in the rat.
Magboul BI; Bender DA
Br J Nutr; 1983 May; 49(3):321-9. PubMed ID: 6222759
[No Abstract] [Full Text] [Related]
13. Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells.
Bender DA; Olufunwa R
Br J Nutr; 1988 Mar; 59(2):279-87. PubMed ID: 2965917
[TBL] [Abstract][Full Text] [Related]
14. Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease.
Ruggieri S; Falaschi P; Baldassarre M; D'Urso R; De Giorgio G; Rocco A; Agnoli A
Neuropsychobiology; 1982; 8(2):102-8. PubMed ID: 7070643
[TBL] [Abstract][Full Text] [Related]
15. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
Treseder SA; Rose S; Summo L; Jenner P
J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
[TBL] [Abstract][Full Text] [Related]
16. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
Wien Klin Wochenschr; 1979 May; 91(10):332-7. PubMed ID: 452602
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tryptophan hydroxylase by benserazide and other catechols.
Johansen PA; Wolf WA; Kuhn DM
Biochem Pharmacol; 1991 Feb; 41(4):625-8. PubMed ID: 1997008
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.
Zimmermann H; Ganong WF
Neuroendocrinology; 1980; 30(2):101-7, 109. PubMed ID: 6986577
[TBL] [Abstract][Full Text] [Related]
19. Effects of a dietary excess of leucine on the metabolism of tryptophan in the rat: a mechanism for the pellagragenic action of leucine.
Bender DA
Br J Nutr; 1983 Jul; 50(1):25-32. PubMed ID: 6882730
[TBL] [Abstract][Full Text] [Related]
20. Vitamin B1 deficiency inhibits the increased conversion of tryptophan to nicotinamide in severe food-restricted rats.
Shibata K; Kobayashi R; Fukuwatari T
Biosci Biotechnol Biochem; 2015; 79(1):103-8. PubMed ID: 25253514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
